SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudeep Pharma - Quaterly Results

20 Dec 2025 Evaluate
The sales slipped to Rs. 878.82 millions for the September 2025 quarter as against Rs. 1062.96 millions during the year-ago period.A meek growth of 0.99% was reported for the quarter ended September 2025 to Rs. 297.42  millions from Rs. 294.51 millions.Operating Profit saw a handsome growth to 437.06 millions from 416.37 millions in the quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202509 202409 % Var
Sales 878.82 1062.96 -17.32 878.82 1062.96 -17.32 878.82 1062.96 -17.32
Other Income 128.27 14.43 788.91 128.27 14.43 788.91 128.27 14.43 788.91
PBIDT 437.06 416.37 4.97 437.06 416.37 4.97 437.06 416.37 4.97
Interest 20.29 7.05 187.80 20.29 7.05 187.80 20.29 7.05 187.80
PBDT 416.77 409.32 1.82 416.77 409.32 1.82 416.77 409.32 1.82
Depreciation 17.73 14.67 20.86 17.73 14.67 20.86 17.73 14.67 20.86
PBT 399.04 394.65 1.11 399.04 394.65 1.11 399.04 394.65 1.11
TAX 101.62 100.14 1.48 101.62 100.14 1.48 101.62 100.14 1.48
Deferred Tax 4.86 2.46 97.56 4.86 2.46 97.56 4.86 2.46 97.56
PAT 297.42 294.51 0.99 297.42 294.51 0.99 297.42 294.51 0.99
Equity 97.23 38.05 155.53 97.23 38.05 155.53 97.23 38.05 155.53
PBIDTM(%) 49.73 39.17 26.96 49.73 39.17 26.96 49.73 39.17 26.96

Sudeep Pharma Share Price

610.30 -3.45 (-0.56%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×